30 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 30 of 30 clinical reviews.
A breakdown of the pharmacodynamic and pharmacokinetic relationship between CJC-1295 (modified GRF) and 5-HTP, covering serotonin syndrome risk, dose-separation windows, monitoring, and when to stop.
Alpha-lipoic acid and CJC-1295 (modified GRF 1-29) share overlapping effects on blood glucose and thyroid hormone metabolism. Learn the pharmacodynamic interaction, dose-separation strategy, and monitoring plan.
A guide covering the pharmacodynamic interactions between ashwagandha (KSM-66 / Sensoril) and CJC-1295 modified GRF, including cortisol modulation, GH axis effects, thyroid impact, and practical dosing guidance.
A guide to combining berberine with CJC-1295 modified GRF: pharmacokinetic interactions, pharmacodynamic overlap, glucose monitoring, dosing strategy, and when to hold one agent.
A breakdown of the caffeine and CJC-1295 interaction: pharmacokinetics, pharmacodynamics, glucose effects, blood pressure, timing windows, and monitoring guidance.
Evidence-based guide on combining calcium supplements with CJC-1295 (modified GRF 1-29). Covers pharmacokinetic and pharmacodynamic considerations, dose-separation windows, and monitoring recommendations.
A guide covering the pharmacokinetics, pharmacodynamics, safety profile, and clinical monitoring recommendations for combining CoQ10 with CJC-1295 modified GRF.
Evidence-based guide on combining creatine supplementation with CJC-1295 (modified GRF 1-29). Covers the creatinine elevation concern, renal monitoring protocols, dose-separation windows, and clinical safety data.
A guide covering the pharmacology of CJC-1295 modified GRF and folate, any known interactions, MTHFR considerations, dosing windows, and monitoring recommendations.
A clinical review of the pharmacodynamic and pharmacokinetic interactions between ginseng and CJC-1295 modified GRF, including glucose effects, anticoagulant potentiation, monitoring parameters, and dosing guidance from a board-certified medical team.
A guide covering the pharmacokinetic and pharmacodynamic interaction between CJC-1295 (modified GRF) and glutathione, including dosing windows, monitoring, and clinical safety considerations.
A guide to combining glycine with CJC-1295 modified GRF: mechanism, pharmacodynamic interactions, dosing windows, glycemic monitoring, and safety evidence.
Evidence-based guide on combining green tea extract (EGCG) with CJC-1295 modified GRF. Covers pharmacokinetic and pharmacodynamic interaction concerns, hepatotoxicity risk, dose-separation strategies, and monitoring recommendations.
A guide to combining L-theanine with CJC-1295 (modified GRF). Covers mechanisms, any pharmacokinetic or pharmacodynamic interactions, dosing windows, and clinical monitoring.
A guide to combining lion's mane mushroom with CJC-1295 modified GRF: mechanism, interaction type, safety data, monitoring, and dosing guidance.
A guide to the CJC-1295 and magnesium interaction: mechanisms, safety, dosing timing, monitoring, and clinical recommendations for patients on GH secretagogue therapy.
Evidence-based guide to combining melatonin with CJC-1295 modified GRF. Covers pharmacokinetic and pharmacodynamic interaction mechanisms, dose-separation windows, glucose monitoring, and clinical recommendations.
Evidence-based guide on combining NAC with CJC-1295 modified GRF. Covers interaction mechanisms, dose-separation windows, monitoring, and safety considerations.
A clinically reviewed guide to combining omega-3 (EPA/DHA) with CJC-1295 modified GRF, covering pharmacodynamic interactions, antiplatelet concerns, triglyceride monitoring, and practical dosing guidance.
Evidence-based guide to taking quercetin with CJC-1295 modified GRF. Covers CYP3A4 inhibition, pharmacokinetic overlap, dose-separation strategy, and clinical monitoring.
A guide to the CJC-1295 and reishi mushroom interaction: mechanisms, safety evidence, monitoring parameters, and clinical recommendations.
A guide to combining resveratrol with CJC-1295 (modified GRF). Covers pharmacokinetic interactions, CYP3A4 metabolism, estrogenic activity, GH/IGF-1 effects, safe dosing windows, and monitoring recommendations.
A guide to combining rhodiola rosea with CJC-1295 modified GRF, covering mechanism, pharmacodynamic interactions, serotonin considerations, cortisol overlap, dosing windows, and monitoring.
A guide to the pharmacodynamic and pharmacokinetic relationship between saw palmetto and CJC-1295 (modified GRF), covering interaction mechanisms, monitoring, and dosing guidance.
St. John's Wort is a potent CYP3A4 inducer that may alter CJC-1295 metabolism. Learn the pharmacokinetic interaction, dose-separation strategies, monitoring recommendations, and what to do if you already take both.
A guide to the pharmacokinetic and pharmacodynamic interactions between CJC-1295 (modified GRF) and turmeric / curcumin, including dosing windows, monitoring, and safety evidence.
Evidence-based guide on combining vitamin B12 supplementation with CJC-1295 modified GRF, covering interaction risk, dose timing, monitoring, and clinical considerations.
A guide covering the pharmacokinetic and pharmacodynamic interaction between vitamin B6 and CJC-1295 modified GRF, including safe dosing ranges, monitoring recommendations, and what to do if you are already taking both.
Evidence-based guide on combining vitamin D supplementation with CJC-1295 modified GRF. Covers interaction mechanisms, dosing windows, monitoring labs, and safety considerations.
Evidence-based guide on combining zinc supplements with CJC-1295 modified GRF. Covers pharmacokinetic and pharmacodynamic interactions, dose-separation windows, copper balance, and clinical monitoring.